WCM
USNA icon

Wedge Capital Management’s Usana Health Sciences USNA Stock Holding History

Wedge Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,004
Closed -$318K – 614
2019
Q2 		$318K Buy
4,004
+834
+26% +$66.1K ﹤0.01% 521
2019
Q1 		$266K Buy
+3,170
New +$331K ﹤0.01% 539

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedge Capital Management's USNA Position: Q3 2019 in Review

Wedge Capital Management sold out of Usana Health Sciences (USNA) in Q3 2019, closing a stake of 4,004 shares — an estimated $318K sold.

Wedge Capital Management first reported a position in USNA in Q1 2019 and held it in 2 quarters. The position peaked at $318K in Q2 2019. 169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

  • Wedge Capital Management reported no remaining Usana Health Sciences position as of Q3 2019 after selling out during the quarter.
  • Wedge Capital Management sold 4,004 Usana Health Sciences shares in Q3 2019, an estimated $318K.
  • Wedge Capital Management first reported a position in Usana Health Sciences in Q1 2019 and held it in 2 quarters.
  • Wedge Capital Management's Usana Health Sciences position peaked at $318K in Q2 2019.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Wedge Capital Management's 13F filing for Q3 2019, filed 1 Nov 2019.